1 completed. .
Follow Delta-Beta Thalassemia: new trials by email Literature Review of Delta-Beta Thalassemia trials Research Report on Delta-Beta Thalassemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19 Non applicable, is a patient registry - Hemoglobinopathies, Sickle Cell Disease | Completed | Hospital Universitari Vall d'Hebron Research Institute | 684 | 2020-04-15 | 2025-02-18 |
Anemia (1) · Anemia, Sickle Cell (1) · Beta Thalassemia, Dominant Inclusion Body Type (1) · COVID-19 (1) · Elliptocytosis, Hereditary (1) · Hemoglobin SC Disease (1) · Hemoglobinopathies (1) · Spherocytosis, Hereditary (1) · alpha-Thalassemia (1) · beta-Thalassemia (1)
Anemia, Hemolytic (1) · Anemia, Hemolytic, Congenital (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Genetic Diseases, Inborn (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Infections (1) · Lung Diseases (1) · Nidovirales Infections (1) · Pneumonia (1) · Pneumonia, Viral (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1)
Hospital Universitari Vall d'Hebron Research Institute (1)
Spain (1)